Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Gynecology

Fertility and Building Your Future Family

At a Glance

Chronic salpingo-oophoritis does not make pregnancy impossible, but inflammation can scar or block the fallopian tubes and reduce fertility. Testing helps guide tubal surgery, tube removal or blocking before IVF, while pregnancy monitoring is important because ectopic risk may remain higher.

For many people diagnosed with chronic salpingo-oophoritis, the most pressing concern is how the condition affects the ability to conceive. While the diagnosis can be intimidating, it does not mean pregnancy is impossible. Instead, it changes the roadmap for how you might achieve a healthy pregnancy, often moving from “unassisted” conception to more specialized fertility care [1][2].

Understanding Tubal-Factor Infertility

The primary challenge following chronic inflammation is tubal-factor infertility (TFI). This occurs when the fallopian tubes are physically blocked or damaged by scar tissue, preventing the egg and sperm from meeting or preventing a fertilized egg from reaching the uterus [3].

The risk of infertility is cumulative. Research indicates that the hazard of tubal-factor infertility increases with each episode of Pelvic Inflammatory Disease (PID) or infection [1][4]. In a major cohort study, women with a history of infection had a significantly higher risk of being diagnosed with TFI compared to those with no such history [5]. When the condition involves a tubo-ovarian abscess (TOA), the risk may be higher due to the intensity of the inflammation and the likelihood of dense adhesions (internal scarring) [6]. Keep in mind that a comprehensive fertility evaluation also considers your age, the health of your uterus, and your partner’s semen analysis.

The Impact of Hydrosalpinx

If your imaging shows a hydrosalpinx—a tube that is not just blocked but filled with fluid—it has a unique impact on fertility:

  • Reduced Natural Conception: Natural pregnancy occurs at significantly lower rates in patients with bilateral (both sides) hydrosalpinx compared to those with healthy, open tubes [7].
  • The Effect on IVF: Even when bypassing the tubes with In Vitro Fertilization (IVF), the presence of a hydrosalpinx can be problematic. The fluid inside the tube may “leak” back into the uterus, where it can create a hostile environment that reduces the chance of an embryo successfully implanting, potentially lowering IVF success rates [8][9].

Strategic Conception: Surgery vs. IVF

Choosing the right path depends on the severity of your tubal damage and your personal goals.

1. Corrective Tubal Surgery

For patients with mild disease who wish to conceive naturally, surgeons may perform fimbrioplasty or neosalpingostomy to reopen the tubes [10].

  • Success Rates: In selected patients, intrauterine pregnancy rates after tubal surgery are variable, though some studies report ranges around 26-27% [10][11].
  • The Risk: These surgeries carry an increased risk of ectopic pregnancy (a pregnancy in the tube), with rates depending on the severity of the initial damage [10][12].

2. In Vitro Fertilization (IVF)

IVF is often the preferred choice for those with bilateral severe disease or significant scarring [12].

  • Preparing for Success: To improve outcomes, doctors often recommend salpingectomy (removing the damaged tube) or proximal tubal occlusion (blocking the tube where it meets the uterus) before starting an IVF cycle [8][13]. This decision is individualized and specialist-led, as surgery has its own risks.
  • Ovarian Reserve: While removing a tube can sometimes slightly lower markers of ovarian reserve like AMH (Anti-Müllerian Hormone), it generally does not reduce the number of eggs successfully retrieved during an IVF cycle [14][15]. Keep in mind AMH is a marker of reserve, not a direct measure of egg quality.

Long-Term Reproductive Outlook

Statistically, people with a history of PID have a higher risk of experiencing an ectopic pregnancy [16][17]. Even after successful IVF, this risk remains slightly elevated because embryos can occasionally migrate into a damaged tube [17].

While the journey may involve more steps, identifying the specific nature of your tubal health allows you and your care team to choose the strategy—whether surgical repair or IVF—that offers the highest chance of a successful live birth [18][19].

Common questions in this guide

Can chronic salpingo-oophoritis make pregnancy impossible?
No. Pregnancy may still be possible, but inflammation can leave scar tissue that blocks or damages the fallopian tubes, making it harder for egg and sperm to meet. A fertility evaluation can help identify the safest and most effective route.
How does a hydrosalpinx affect fertility and IVF?
A hydrosalpinx is a fallopian tube that is blocked and filled with fluid. It can greatly reduce the chance of natural conception, and fluid may flow back toward the uterus and interfere with embryo implantation during IVF. Your specialist may discuss removing the tube or blocking it near the uterus before IVF.
Should I choose tubal surgery or IVF after chronic salpingo-oophoritis?
The choice depends on whether one or both tubes are affected, how much scarring is present, your age, and your fertility goals. Tubal repair may be considered for selected people with milder damage, while IVF is often favored for severe or bilateral disease. Tubal surgery also carries a higher risk of ectopic pregnancy.
What tests can show whether my fallopian tubes are open?
A hysterosalpingogram, called an HSG, or a HyCoSy can assess whether the tubes are open or blocked. A complete fertility evaluation also considers your age, the health of your uterus, and your partner’s semen analysis.
Will removing a damaged fallopian tube lower my ovarian reserve?
Removing a tube may slightly lower AMH, a blood marker of ovarian reserve. However, it generally does not reduce the number of eggs retrieved during IVF, and AMH does not directly measure egg quality. Your fertility specialist can interpret the result in context.
Why will I need early monitoring in a future pregnancy?
A history of pelvic inflammatory disease and tubal damage raises the risk of ectopic pregnancy, even though pregnancy may still be healthy. After IVF, the risk can remain slightly elevated because an embryo can rarely move into a damaged tube. Early blood tests and ultrasounds can help your care team confirm where the pregnancy is developing.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my history, has a hysterosalpingogram (HSG) or HyCoSy been performed to determine if my tubes are open (patent) or blocked (occluded)?
  2. 2.If I have a hydrosalpinx, should I consider salpingectomy (tube removal) or proximal tubal occlusion before starting IVF?
  3. 3.What is my predicted 'intrauterine pregnancy rate' versus my 'ectopic pregnancy rate' if I choose tubal surgery instead of IVF?
  4. 4.How will my prior tubo-ovarian abscess (TOA) specifically affect my ovarian reserve and the number of eggs we might retrieve during IVF?
  5. 5.Do you recommend checking my AMH levels now to see how the inflammation or prior surgeries have affected my egg count?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark.

    Davies B, Turner KME, Frølund M, et al.

    The Lancet. Infectious diseases 2016; (16(9)):1057-1064 doi:10.1016/S1473-3099(16)30092-5.

    PMID: 27289389
  2. 2

    The value of transvaginal 4-dimensional hysterosalpingo-contrast sonography in predicting the necessity of assisted reproductive technology for women with tubal factor infertility.

    Gu P, Yang X, Zhao X, Xu D

    Quantitative imaging in medicine and surgery 2021; (11(8)):3698-3714 doi:10.21037/qims-20-1193.

    PMID: 34341743
  3. 3

    Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention.

    Curry A, Williams T, Penny ML

    American family physician 2019; (100(6)):357-364.

    PMID: 31524362
  4. 4

    Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients.

    den Heijer CDJ, Hoebe CJPA, Driessen JHM, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019; (69(9)):1517-1525 doi:10.1093/cid/ciz429.

    PMID: 31504315
  5. 5

    Reproductive tract complication risks following Chlamydia trachomatis infections: a long-term prospective cohort study from 2008 to 2022.

    Alexiou ZW, Hoenderboom BM, Hoebe CJPA, et al.

    The Lancet regional health. Europe 2024; (45()):101027 doi:10.1016/j.lanepe.2024.101027.

    PMID: 39247903
  6. 6

    Relationships between female infertility and female genital infections and pelvic inflammatory disease: a population-based nested controlled study.

    Tao X, Ge SQ, Chen L, et al.

    Clinics (Sao Paulo, Brazil) 2018; (73()):e364 doi:10.6061/clinics/2018/e364.

    PMID: 30110069
  7. 7

    Evaluation of pregnancy outcomes using a novel hysterosalpingography scoring system for tubal patency.

    Yang H, Xu Y, Cheng S, et al.

    European journal of obstetrics & gynecology and reproductive biology: X 2026; (29()):100437 doi:10.1016/j.eurox.2025.100437.

    PMID: 41438868
  8. 8

    Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

    Melo P, Georgiou EX, Johnson N, et al.

    The Cochrane database of systematic reviews 2020; (10()):CD002125 doi:10.1002/14651858.CD002125.pub4.

    PMID: 33091963
  9. 9

    Hydrosalpinx - Salpingostomy, salpingectomy or tubal occlusion.

    Ng KYB, Cheong Y

    Best practice & research. Clinical obstetrics & gynaecology 2019; (59()):41-47 doi:10.1016/j.bpobgyn.2019.01.011.

    PMID: 30824209
  10. 10

    Laparoscopic Fimbrioplasty and Neosalpingostomy in Female Infertility: A Review of 402 Cases at the Gynecological Endoscopic Surgery and Human Reproductive Teaching Hospital in Yaoundé-Cameroon.

    Kasia JM, Ngowa JD, Mimboe YS, et al.

    Journal of reproduction & infertility 2016; (17(2)):104-9.

    PMID: 27141465
  11. 11

    Which patients with hydrosalpinx will benefit more from reproductive surgery to improve natural pregnancy outcomes?: A systematic review and meta-analysis.

    Hao HJ, Wang ZH, Feng L, et al.

    Medicine 2023; (102(8)):e32806 doi:10.1097/MD.0000000000032806.

    PMID: 36827021
  12. 12

    Predictive value of a modified classification of fallopian tube status on prognosis of tubal factor infertility after laparoscopic surgery.

    Yuan L, Jingying H, Xiujuan C, et al.

    Medicine 2019; (98(13)):e14952 doi:10.1097/MD.0000000000014952.

    PMID: 30921195
  13. 13

    Hydrosalpinx treatment before in-vitro fertilization: systematic review and network meta-analysis.

    Pérez-Milán F, Caballero-Campo M, Carrera-Roig M, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2025; (65(4)):414-426 doi:10.1002/uog.27697.

    PMID: 38764191
  14. 14

    Effect comparison of salpingectomy versus proximal tubal occlusion on ovarian reserve: A meta-analysis.

    Wu S, Zhang Q, Li Y

    Medicine 2020; (99(30)):e20601 doi:10.1097/MD.0000000000020601.

    PMID: 32791661
  15. 15

    Treatment of hydrosalpinx in relation to IVF outcome: a systematic review and meta-analysis.

    Volodarsky-Perel A, Buckett W, Tulandi T

    Reproductive biomedicine online 2019; (39(3)):413-432 doi:10.1016/j.rbmo.2019.04.012.

    PMID: 31324437
  16. 16

    Association of pelvic inflammatory disease (PID) with ectopic pregnancy and preterm labor in Taiwan: A nationwide population-based retrospective cohort study.

    Huang CC, Huang CC, Lin SY, et al.

    PloS one 2019; (14(8)):e0219351 doi:10.1371/journal.pone.0219351.

    PMID: 31408465
  17. 17

    Top-quality embryo transfer is associated with lower odds of ectopic pregnancy.

    Anzhel S, Mäkinen S, Tinkanen H, et al.

    Acta obstetricia et gynecologica Scandinavica 2022; (101(7)):779-786 doi:10.1111/aogs.14375.

    PMID: 35546786
  18. 18

    Pre- and Procedural Factors Influencing the Success of In Vitro Fertilization: Evaluating Embryo Quality and Clinical Pregnancy in Cases of Tubal Factor Infertility.

    Kozinszky Z, Bereczki K, Vedelek V, et al.

    Journal of clinical medicine 2024; (13(19)) doi:10.3390/jcm13195754.

    PMID: 39407814
  19. 19

    Tubal factor infertility with prior ectopic pregnancy: a double whammy? A retrospective cohort study of 2,892 women.

    Cai H, Mol BW, Li P, et al.

    Fertility and sterility 2020; (113(5)):1032-1038 doi:10.1016/j.fertnstert.2019.12.036.

    PMID: 32143813

This page discusses how chronic salpingo-oophoritis may affect fertility and pregnancy planning for informational purposes only; it does not constitute medical advice or replace care from a gynecologist or fertility specialist. Ask your clinician to interpret your tube tests, ovarian reserve results, and treatment options.

Get notified when new evidence is published on chronic salpingo-oophoritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.